606 related articles for article (PubMed ID: 35766483)
1. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbial and Associated Metabolite Markers for Colorectal Cancer Diagnosis.
Alhhazmi AA; Alhamawi RM; Almisned RM; Almutairi HA; Jan AA; Kurdi SM; Almutawif YA; Mohammed-Saeid W
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630597
[TBL] [Abstract][Full Text] [Related]
4. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
6. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
8. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
9. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
Liu NN; Jiao N; Tan JC; Wang Z; Wu D; Wang AJ; Chen J; Tao L; Zhou C; Fang W; Cheong IH; Pan W; Liao W; Kozlakidis Z; Heeschen C; Moore GG; Zhu L; Chen X; Zhang G; Zhu R; Wang H
Nat Microbiol; 2022 Feb; 7(2):238-250. PubMed ID: 35087227
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
11. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
12. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
13. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic analysis of the interaction between the gut microbiota and colorectal cancer: a paired-sample study based on the GMrepo database.
Chen H; Jiao J; Wei M; Jiang X; Yang R; Yu X; Zhang G; Zhou X
Gut Pathog; 2022 Dec; 14(1):48. PubMed ID: 36564826
[TBL] [Abstract][Full Text] [Related]
15. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
[TBL] [Abstract][Full Text] [Related]
16. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
[TBL] [Abstract][Full Text] [Related]
17. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
19. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
[TBL] [Abstract][Full Text] [Related]
20. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
